Abstract
A decentralized pharmacosurveillance system has been set up in France since 1974. During the first years (1974–1976) reference centers (Centres de Pharmacovigilance) were created in five departments of pharmacology. The role of these centers was to: 1) answer inquiries about drug safety from practitioners, and 2) collect the cases of adverse drug reactions (ADRs) occurring in the area. These centers applied the same principle: a good information service is the best way of getting new information. The number of these “Centres de Pharmacovigilance” increased each year until 1982, date of the official recognition of pharmacovigilance in France by the Decree of July 30th, 1982.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Begaud, B. (1992). Pharmacovigilance in France: A Decentralized Approach. In: Strom, B.L., Velo, G. (eds) Drug Epidemiology and Post-Marketing Surveillance. NATO ASI Series, vol 224. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2587-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2587-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2589-3
Online ISBN: 978-1-4899-2587-9
eBook Packages: Springer Book Archive